First Session Topic: Providing Guidance to In Vitro Modeling Standards for Toxicity to Align with FDA Expectation & Good Laboratory Practice
2:45 pm - Thursday 29th January 2026
- Clarifying FDA requirements with robust in vitro models and refined assays to reduce uncertainty and animal reliance